| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.39 | 4e-15 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.0009 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |